TY - JOUR
T1 - Neurofibromatosis 1 ((NF1)) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene
AU - Danglot, Glséle
AU - Régnler, Vinclane
AU - Fauvet, Didier
AU - Vassal, Gilles
AU - Kujas, Michéle
AU - Bernheim, Alain
N1 - Funding Information:
We are grateful to Dr Terrier, Dr Contesso, Dr Prade, Dr Caillou, Dr Temer-Lacombe and their collaborators from the Anatomopathology Departments of Institut Gustave Roussy, Dr Lellouch-Tubiana from Necker-Enfanls-Malades Hospital and Dr Gaspard from Pitii-Salpe'tnere Hospital for providing the normal tissues and tumors analysed in this study. We also thank Dr Bruce Korf (Harvard Medical School) and the members of the International NFI Genetic Analysis Consortium for the rapid diffusion of information.We thank Ms L.Saint Ange for editing the manuscript and G.Me'rault for the photographs. This work was supported by grants from the CNRS, Institut Gustave Roussy and Association pour la Recherche contre le Cancer.
PY - 1995/5/1
Y1 - 1995/5/1
N2 - The neurofibromatosis 1 gene seems to play essential roles at several different stages of life. During embryogenesis, it is involved in cardiac development while in the adult, neurofibromin (the corresponding protein) is mainly expressed In the nervous system, and therein, essentially in neurons, non-myeiinating Schwann cells and ollgodendrocytes. In addition, the NF1 gene is considered a tumor suppressor gene, since mutations have been associated with the occurrence of benign and malignant tumors in neuralcrest-derived tissues. Using reverse transcription polymerase chain reaction (RT-PCR) analyses with primers located in exons 7 and 13, we have identified evidence of alternative splicing in this region of the NF1 gene. Cloning and sequencing of cDNA allowed the characterization of an isotorm bearing an extra 30 bp sequence between exons 9 and 10a, leading to the insertion of 10 amino acids between residues 420 and 421 of neurofibromin. The insertion is conserved in the mouse. Examination of the pattern of expres sion of this isoform demonstrated a high level of expression in the central nervous system and an absence of expression in all the other normal tissues tested including peripheral nervous tissues derived from the neural crest. Analysis of brain tumors indi cated a reduced expression of the alternative exon in meduiloblastomas and oligodendrogliomas. The results presented here are consistent with tissuespecific expression of this alternative exon which we propose to call exon 9br.
AB - The neurofibromatosis 1 gene seems to play essential roles at several different stages of life. During embryogenesis, it is involved in cardiac development while in the adult, neurofibromin (the corresponding protein) is mainly expressed In the nervous system, and therein, essentially in neurons, non-myeiinating Schwann cells and ollgodendrocytes. In addition, the NF1 gene is considered a tumor suppressor gene, since mutations have been associated with the occurrence of benign and malignant tumors in neuralcrest-derived tissues. Using reverse transcription polymerase chain reaction (RT-PCR) analyses with primers located in exons 7 and 13, we have identified evidence of alternative splicing in this region of the NF1 gene. Cloning and sequencing of cDNA allowed the characterization of an isotorm bearing an extra 30 bp sequence between exons 9 and 10a, leading to the insertion of 10 amino acids between residues 420 and 421 of neurofibromin. The insertion is conserved in the mouse. Examination of the pattern of expres sion of this isoform demonstrated a high level of expression in the central nervous system and an absence of expression in all the other normal tissues tested including peripheral nervous tissues derived from the neural crest. Analysis of brain tumors indi cated a reduced expression of the alternative exon in meduiloblastomas and oligodendrogliomas. The results presented here are consistent with tissuespecific expression of this alternative exon which we propose to call exon 9br.
UR - http://www.scopus.com/inward/record.url?scp=0029060437&partnerID=8YFLogxK
U2 - 10.1093/hmg/4.5.915
DO - 10.1093/hmg/4.5.915
M3 - Article
C2 - 7633452
AN - SCOPUS:0029060437
SN - 0964-6906
VL - 4
SP - 915
EP - 920
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 5
ER -